sgScd2/sgIrf9_IP (n=1)
source_name
Spleen
strain
C57BL/6
tissue
Spleen
cell type
Naive CD4 T Cells
antibody
IRF9
genotype
SCD2/IRF9 DKO
treatment
stimulated under Th1 culture conditions (10 ng/ml IL-12) for 5 days in vitro.